0
0The researchers introduce SiamCDR, a novel computational framework designed to improve the prediction of how specific cancer cell lines respond to various drugs. By utilizing contrastive learning and Siamese neural networks, the model creates highly expressive digital representations that group drugs by their molecular mechanisms and cell lines by their cancer types. The study demonstrates that SiamCDRRF, a version using a random forest classifier, significantly outperforms existing state-of-the-art methods by providing more personalized treatment prioritizations. Beyond identifying established FDA-approved therapies, the framework successfully suggests drug repurposing candidates for difficult-to-treat malignancies like bladder and prostate cancers. Furthermore, the model shows a sophisticated ability to recognize transcriptomic signals of drug resistance, offering a potentially vital tool for advancing the accuracy of precision oncology.
References:
Lawrence, P.J., Burns, B. & Ning, X. Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization. npj Precis. Onc. 8, 106 (2024). doi.org
